Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma

Glioblastoma (GBM) is the most common and highly lethal type of brain tumor, with poor survival despite advances in understanding its complexity. After current standard therapeutic treatment, including tumor resection, radiotherapy and concomitant chemotherapy with temozolomide, the median overall s...

Descripción completa

Detalles Bibliográficos
Autores principales: Drakulic, Danijela, Schwirtlich, Marija, Petrovic, Isidora, Mojsin, Marija, Milivojevic, Milena, Kovacevic-Grujicic, Natasa, Stevanovic, Milena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406959/
https://www.ncbi.nlm.nih.gov/pubmed/36010607
http://dx.doi.org/10.3390/cells11162530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406959/
https://www.ncbi.nlm.nih.gov/pubmed/36010607
http://dx.doi.org/10.3390/cells11162530

Ejemplares similares